(1)
Chemotherapy-Related Agranulocytosis As a Predictive Factor for Germline BRCA1 Pathogenic Variants in Breast Cancer Patients: A Retrospective Cohort Study. Swiss Med Wkly 2023, 153 (3), 40055. https://doi.org/10.57187/smw.2023.40055.